Literature DB >> 10506195

A hydrophobic region locating at the center of fibroblast growth factor-9 is crucial for its secretion.

K Miyakawa1, K Hatsuzawa, T Kurokawa, M Asada, T Kuroiwa, T Imamura.   

Abstract

Fibroblast growth factor (FGF)-9 is a glycosylated neurotrophic polypeptide highly expressed in brain. The mechanism for its secretion from expressing cells is unclear, because its primary structure lacks a cleavable signal sequence. We, therefore, investigated the mechanism and structural requirements for secretion of FGF-9. As with other secreted proteins, in vitro translation of FGF-9 was inhibited by signal recognition particle, which binds to the signal sequence. When translated in vitro, full-length FGF-9 was translocated into microsomes, glycosylated, and protected from trypsin digestion. By using various FGF-9 deletion mutants, we found that two hydrophobic domains, located at the N terminus and at the center of the FGF-9 primary structure, were crucial for translocation. Examination of various point mutants revealed that local hydrophobicity of the central hydrophobic domain, but not the N terminus, was crucial for translocation. Analogous results were obtained with respect to FGF-9 secretion from transfectant cells. Upon deletion of the complete sequence preceding it, the previously uncleavable hydrophobic domain appeared to serve as a cleavable signal sequence. Our results suggest that nascent FGF-9 polypeptides translocate into endoplasmic reticulum without peptide cleavage via a co-translational pathway in which both the N terminus and the central hydrophobic domain are important; thereafter, FGF-9 is glycosylated and secreted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506195     DOI: 10.1074/jbc.274.41.29352

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  J Biochem       Date:  2010-10-12       Impact factor: 3.387

Review 2.  Secretion without Golgi.

Authors:  Igor Prudovsky; Francesca Tarantini; Matteo Landriscina; David Neivandt; Raffaella Soldi; Aleksandr Kirov; Deena Small; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

3.  Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.

Authors:  Yuko Kojima; Masafumi Nakayama; Takashi Nishina; Hiroyasu Nakano; Makoto Koyanagi; Kazuyoshi Takeda; Ko Okumura; Hideo Yagita
Journal:  J Biol Chem       Date:  2011-10-21       Impact factor: 5.157

4.  FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development.

Authors:  Shun Yan Lu; David P Sontag; Karen A Detillieux; Peter A Cattini
Journal:  Am J Physiol Cell Physiol       Date:  2008-03-12       Impact factor: 4.249

5.  PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines.

Authors:  Takeo Minematsu; Noboru Egashira; Hanako Kajiya; Mao Takei; Susumu Takekoshi; Yoshiko Itoh; Hideo Tsukamoto; Johbu Itoh; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

6.  Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene.

Authors:  Xiao-Lin Wu; Ming-Min Gu; Lei Huang; Xue-Song Liu; Hong-Xin Zhang; Xiao-Yi Ding; Jian-Qiang Xu; Bin Cui; Long Wang; Shun-Yuan Lu; Xiao-Yi Chen; Hai-Guo Zhang; Wei Huang; Wen-Tao Yuan; Jiang-Ming Yang; Qun Gu; Jian Fei; Zhu Chen; Zhi-Min Yuan; Zhu-Gang Wang
Journal:  Am J Hum Genet       Date:  2009-07       Impact factor: 11.025

Review 7.  Fibroblast growth factors.

Authors:  D M Ornitz; N Itoh
Journal:  Genome Biol       Date:  2001-03-09       Impact factor: 13.583

Review 8.  The Fibroblast Growth Factor signaling pathway.

Authors:  David M Ornitz; Nobuyuki Itoh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-13       Impact factor: 5.814

9.  The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis.

Authors:  Hengliang Shi; Chunling Fu; Wei Wang; Yu Li; Shuang Du; Rangjuan Cao; Jingying Chen; Dong Sun; Zhongyu Zhang; Xingzhi Wang; Xiaojuan Zhu
Journal:  J Cell Mol Med       Date:  2014-08-15       Impact factor: 5.310

Review 10.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.